3 unknown, 2 completed. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Unknown 1 |
Follow SENAI CIMATEC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Probiotic Compound K11T e K11TMax in ASD Inflammatory level, Cognitive assessment, Pedagogical assessment - Autism Spectrum Disorder | Not applicable | Completed | Deivis de Oliveira guimaraes | 505 | 2024-03-22 | 2024-10-03 |
| Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury Mesenchymal stem cell transplantation, Placebo - Spinal Cord Injuries | Phase 2 | Unknown | SENAI CIMATEC | 40 | 2023-04-01 | 2023-01-12 |
| Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine RNA MCTI CIMATEC HDT 5µg, RNA MCTI CIMATEC HDT 10µg, Covishield® - AstraZeneca - COVID-19, COVID-19 Vaccine | Phase 2 | Unknown | Azidus Brasil | 300 | 2023-01-01 | 2022-09-15 |
| Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19 Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine, Cohort 2 RNA VACCINE MCTI CIMATEC HDT(HDT-301) vaccine, Cohort 3 VACCINE RNA MCTI CIMATEC HDT(HDT-301) vaccine - SARS-CoV-2 | Phase 1 | Unknown | SENAI CIMATEC | 90 | 2022-01-13 | 2022-04-04 |
| Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo - COVID-19 Virus Infection | Phase 2 | Completed | SENAI CIMATEC | 224 | 2021-03-01 | 2022-07-07 |
COVID-19 (2) · Autism Spectrum Disorder (1) · Child Development Disorders, Pervasive (1) · Spinal Cord Injuries (1)
repRNA-CoV2S vaccine (2) · Carnitine (1) · Dosage Forms (1) · Mental Status and Dementia Tests (1) · Mesenchymal Stem Cell Transplantation (1) · Vaccines (1)
Brazil (4)
Augusto Mota, PhD (1) · Deivis O Guimaraes, PhD student (1) · Milena Soares, PhD (1) · Steven Reed, PhD (1)